IRIS UniCatt

Graziani, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.985
AS - Asia 3.714
EU - Europa 3.051
SA - Sud America 743
AF - Africa 115
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 7
Totale 11.626
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.852
SG - Singapore 1.658
CN - Cina 910
DE - Germania 800
IT - Italia 623
BR - Brasile 619
SE - Svezia 461
VN - Vietnam 338
FR - Francia 319
GB - Regno Unito 180
IE - Irlanda 155
IN - India 133
JP - Giappone 118
ID - Indonesia 103
HK - Hong Kong 98
FI - Finlandia 91
UA - Ucraina 83
RU - Federazione Russa 78
CA - Canada 69
BD - Bangladesh 53
KR - Corea 52
NL - Olanda 52
AR - Argentina 46
PL - Polonia 44
IQ - Iraq 41
TR - Turchia 40
ZA - Sudafrica 40
MX - Messico 39
AT - Austria 36
ES - Italia 23
IR - Iran 20
EC - Ecuador 19
PK - Pakistan 19
SA - Arabia Saudita 18
BE - Belgio 17
VE - Venezuela 17
CI - Costa d'Avorio 16
JO - Giordania 16
UZ - Uzbekistan 14
CO - Colombia 12
IL - Israele 12
LT - Lituania 12
MA - Marocco 12
CL - Cile 11
EG - Egitto 10
AU - Australia 9
CH - Svizzera 9
AE - Emirati Arabi Uniti 8
KE - Kenya 8
RO - Romania 8
DZ - Algeria 7
NP - Nepal 7
PE - Perù 7
PH - Filippine 7
TN - Tunisia 7
GR - Grecia 6
KZ - Kazakistan 6
PY - Paraguay 6
CU - Cuba 5
CZ - Repubblica Ceca 5
HR - Croazia 5
HU - Ungheria 5
PS - Palestinian Territory 5
PT - Portogallo 5
AL - Albania 4
AZ - Azerbaigian 4
BG - Bulgaria 4
JM - Giamaica 4
KH - Cambogia 4
LB - Libano 4
LV - Lettonia 4
MD - Moldavia 4
MK - Macedonia 4
SN - Senegal 4
TH - Thailandia 4
UY - Uruguay 4
AO - Angola 3
BY - Bielorussia 3
CY - Cipro 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
HN - Honduras 3
MY - Malesia 3
NO - Norvegia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BH - Bahrain 2
EU - Europa 2
KW - Kuwait 2
LK - Sri Lanka 2
NZ - Nuova Zelanda 2
PA - Panama 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
A1 - Anonimo 1
Totale 11.607
Salva come PNG Salva come JPEG
Città #
Singapore 939
Ashburn 492
San Jose 478
Chandler 472
Beijing 195
New York 161
Hefei 151
Rome 147
Dublin 145
Ho Chi Minh City 119
Tokyo 108
Los Angeles 107
Lauterbourg 106
St Louis 106
The Dalles 104
Jakarta 90
Hanoi 89
Hong Kong 87
Milan 85
Frankfurt am Main 78
Marseille 64
San Mateo 63
São Paulo 61
Munich 59
Nanjing 56
Boston 55
Jacksonville 54
Moscow 50
Seoul 49
Ann Arbor 45
Helsinki 42
Kent 42
Wilmington 42
Dallas 39
London 38
Nürnberg 36
Houston 35
Buffalo 34
Nuremberg 34
Princeton 30
Bremen 29
Stockholm 29
Seattle 28
Warsaw 28
Santa Clara 27
Cattolica 23
Council Bluffs 23
Chennai 22
Chicago 22
Orem 22
Paris 22
Johannesburg 21
Lappeenranta 21
Rio de Janeiro 21
Amsterdam 20
Montreal 20
Brooklyn 19
Dearborn 18
Nanchang 18
North Bergen 18
Vienna 18
Washington 18
Baghdad 17
Brussels 17
Denver 17
Düsseldorf 17
Haiphong 17
Mexico City 17
Pune 17
Redwood City 17
Roubaix 17
Tianjin 17
Toronto 17
Abidjan 16
Amman 16
Atlanta 16
Phoenix 15
Poplar 15
Woodbridge 15
Bologna 14
Da Nang 13
Lawrence 13
Mumbai 13
Palermo 13
Tashkent 13
Turku 13
Belo Horizonte 12
Enterprise 12
Manchester 12
Salvador 12
San Francisco 12
Bexley 11
Guangzhou 11
Guarulhos 11
Brasília 10
Curitiba 10
Fairfield 10
Falls Church 10
Shanghai 10
Augusta 9
Totale 6.198
Salva come PNG Salva come JPEG
Nome #
Paradoxical preservation of vascular function in severe obesity 355
Growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery 217
Effects of bariatric surgery on cardiac remodeling: clinical and pathophysiologic implications 215
Cardiovascular risk in obesity: different activation of inflammation and immune system between obese and morbidly obese subjects 202
Endothelial progenitor cells in morbid obesity 201
Growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery 195
Thromboxane production in morbidly obese subjects 189
Inflammasome, T Lymphocytes and Innate-Adaptive Immunity Crosstalk: Role in Cardiovascular Disease and Therapeutic Perspectives 169
Right ventricular-pulmonary artery coupling assessed by two-dimensional strain predicts in-hospital complications in Takotsubo syndrome 165
Standard ECG for differential diagnosis between Anderson-Fabry disease and hypertrophic cardiomyopathy 164
Expansion of CD4+CD28null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus 163
Chlamydia pneumoniae in coronary atherosclerotic plaques and coronary instability 163
Dysbiosis, gut microbiota modulation and intestinal permeability in recurrent cystitis patients and concomitant gastrointestinal pathologies 163
Cardiovascular involvement in patients affected by multiple myeloma: a comprehensive review of recent advances 158
Infections, immunity and atherosclerosis: pathogenic mechanisms and unsolved questions 156
Right Ventricular Hypertrophy, Systolic Function, and Disease Severity in Anderson-Fabry Disease: An Echocardiographic Study 156
Coronary Microvascular Dysfunction Is Associated With a Worse Cardiac Phenotype in Patients With Fabry Disease 149
Chlamydia pneumoniae in coronary atherosclerotic plaques and coronary instability 149
Clinical Impact of Heart Team Decisions for Patients With Complex Valvular Heart Disease: A Large, Single-Center Experience 144
Response to letter regarding article, "growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery" 144
Heart Team e malattie valvolari: L’importanza di un approccio multidisciplinare 144
The combined effect of subcutaneous granulocyte- colony stimulating factor and myocardial contrast echocardiography with intravenous infusion of sulfur hexafluoride on post-infarction left ventricular function, the RIGENERA 2.0 trial: study protocol for a randomized controlled trial 142
Early Right Heart Chambers Reverse Remodeling in Patients Operated in Adulthood for Congenital Lesions Associated with Right Heart Chambers Enlargement 131
A multimodal approach to predict prosthesis-patient mismatch in patients undergoing valve-in-valve trans-catheter aortic valve implantation 130
Precision medicine versus standard of care for patients with myocardial infarction with non-obstructive coronary arteries (MINOCA): rationale and design of the multicentre, randomised PROMISE trial 129
Right ventricle systolic function and right ventricle-pulmonary artery coupling in patients with severe aortic stenosis and the early impact of TAVI 126
Acute haemodynamic impact of transcatheter aortic valve implantation in patients with severe aortic stenosis 126
Prevalence and Clinical Correlates of Cerebrovascular Alterations in Fabry Disease: A Cross-Sectional Study 124
Right ventricular strain in Anderson-Fabry disease 124
An uplifted destiny for mucopolysaccharidosis type I with heart involvement 120
Performance, clinical outcomes and implementation of an original heart valve clinic model 119
The Effects of Granulocyte Colony-Stimulating Factor in Patients with a Large Anterior Wall Acute Myocardial Infarction to Prevent Left Ventricular Remodeling: A 10-Year Follow-Up of the RIGENERA Study 118
When compassionate is appropriate for end-stage aortic valve stenosis? 117
Inflammation across the spectrum of hypertrophic cardiac phenotypes 116
Diagnostic role of echocardiography in patients admitted to the emergency room with suspect no-ST-segment elevation acute myocardial infarction 115
Global longitudinal strain for prediction of mortality in ST-segment elevation myocardial infarction and aortic stenosis patients: two sides of the same coin 114
Prognostic significance of right ventricular hypertrophy and systolic function in Anderson–Fabry disease 114
Echocardiographic left atrial stiffness index predicts high left ventricular filling pressures in patients with acute heart failure: an observational study 112
Massive Coronary Microvascular Dysfunction in Severe Anderson-Fabry Disease Cardiomyopathy 112
Pulmonary congestion assessed by lung ultrasound in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: Prevalence and prognostic implications 111
Unexpected Left Ventricle Pseudoaneurysm With Unusual Origin: History of a Diseased Annulus Broken Into a Diseased Myocardium 111
Diagnosis and management of peripartum cardiomyopathy and recurrence risk 110
Transcatheter aortic valve implantation in pure aortic regurgitation: Hemodynamic and echocardiographic findings in bioprosthesis vs. native valve 109
Intestinal permeability in physiological and pathological conditions: major determinants and assessment modalities 108
Valvular heart disease and cardiomyopathy: reappraisal of their interplay 105
Pregnancy outcome and left ventricular ejection fraction in women with history of myocardial infarction 105
Evidence of evolution towards left midventricular obstruction in severe Anderson–Fabry cardiomyopathy 105
Trabecular complexity as an early marker of cardiac involvement in Fabry disease 102
Pulmonary artery sling in a 22-month-old boy with 18q deletion syndrome: A rare but possible association 102
Association of Cardiac Sarcoidosis and Ulcerative Colitis: A Case Report and a Brief Review of the Literature 102
Right ventricular strain in Fabry disease: Prognostic implications 101
Pregnancy outcome and left ventricular ejection fraction in women with history of myocardial infarction 100
Comparative analysis of right ventricular strain in Fabry cardiomyopathy and sarcomeric hypertrophic cardiomyopathy 99
Effect of Migalastat on cArdiac Involvement in FabRry Disease: MAIORA study 99
Impact of Impella protected-percutaneous coronary intervention on left ventricle function recovery of patients with extensive coronary disease and poor left ventricular function 99
Evolution of Cardiac Damage Staged With Echocardiography in Fabry Disease 99
Telemedicine for adult congenital heart disease patients during the first wave of COVID-19 era: a single center experience 98
Successful Transcatheter Treatment of Left Pulmonary Artery to Left Atrium Communication Diagnosed in Adulthood 98
Telemedicine for adult congenital heart disease patients during the first wave of COVID-19 era: a single center experience 98
Right ventricle-pulmonary artery coupling in repaired tetralogy of Fallot with pulmonary regurgitation: Clinical implications 97
Left atrial strain analysis improves left ventricular filling pressures non-invasive estimation in the acute phase of Takotsubo syndrome 97
Right atrial strain in Anderson-Fabry disease 97
Instability mechanisms in unstable angina according to baseline serum levels of C-reactive protein: The role of thrombosis, fibrinolysis and atherosclerotic burden. 97
Transthoracic Echocardiography in Assessing Patients with Suspected Infective Endocarditis (TEASE): An Exploratory Study 96
Atypical Thrombosis Following Mitral Transcatheter Edge-to-Edge Repair: Face to Face Between Scar and Clip 94
Early Hemodynamic and Structural Impact of Transcatheter Aortic Valve Replacement in Pure Aortic Regurgitation 93
Temporal trends of frame expansion and paravalvular leak reduction after transcatheter aortic valve replacement with self-expandable prostheses 92
Impact of severe valvular heart disease in adult congenital heart disease patients 92
Evolution and Prognostic Impact of Right Ventricular-Pulmonary Artery Coupling After Transcatheter Aortic Valve Replacement 91
Impact of Impella protected-percutaneous coronary intervention on left ventricle function recovery of patients with extensive coronary disease and poor left ventricular function 91
Early cardiac mechanics abnormalities in patients with mitochondrial diseases 90
Left atrial structural and functional remodelling in Fabry disease and cardiac amyloidosis: A comparative analysis 89
Evaluation of Adults With Congenital Heart Disease 89
Cardiac Magnetic Resonance Features of Fabry Disease: From Early Diagnosis to Prognostic Stratification 87
Emerging multisystem biomarkers in hereditary transthyretin amyloidosis: a pilot study 87
Comparison of De-Kay repair versus De Vega suture for functional tricuspid regurgitation: a preliminary experience 85
Management, Flow, and Outcomes of Patients with Aortic Stenosis Followed by a Heart Valve Clinic: The Untold "Behind the Scene" from a High-Volume, Real-World Experience 85
The Heart in Fabry Disease: Mechanisms Beyond Storage and Forthcoming Therapies 82
A Novel Hemodynamic Index Characterizing Mitral Regurgitation Undergoing Transcatheter Edge-to-Edge Repair: The MPF 82
Undiagnosed Severe Late Complications of Repaired Tetralogy of Fallot 81
An uplifted destiny for mucopolysaccharidosis type I with heart valve involvement 81
Treating heart failure with preserved ejection fraction: learning from pulmonary fibrosis 79
Early improvement of strain imaging parameters predicts long-term response to sacubitril/valsartan in patients with heart failure with reduced ejection fraction: An observational prospective study 78
ECG-based score estimates the probability to detect Fabry Disease cardiac involvement 76
Anderson-Fabry's Disease: A Rare but Treatable Case of Fever of Unknown Origin 75
Severe silent myocardial ischemia during echocardiographic examination in a patient during cardiac screening for a kidney transplant intervention 75
Non-invasive imaging of ventricular-atrial fistulization secondary to infective rupture of caseous calcification of the mitral annulus 75
An unusual case of mitral valve chordal rupture 72
Pregnancy in hypertrophic cardiomyopathy: New data, old questions 71
Myocardial infarction with non-obstructive coronary arteries in hypertrophic cardiomyopathy vs Fabry disease 71
Généreux staging classification in predicting left ventricular reverse remodeling after intervention for severe aortic valve regurgitation 70
Dynamic modulation of coronary arterio-venous communications 69
Right ventricular to pulmonary artery coupling and prognosis in transthyretin cardiac amyloidosis 68
Modified Warden procedure in adult with partial anomalous pulmonary venous connection after previous atrial septal defect repair 68
Rationale for the Use of Pirfenidone in Heart Failure With Preserved Ejection Fraction 68
Subclinical dysfunction of remote myocardium is related to high NT-proBNP and affects global contractility at follow-up, independently of infarct area 68
Echocardiography in Anderson-Fabry Disease 67
Prognostic Implications of the Extent of Cardiac Damage in Patients With Fabry Disease 64
Potential resistance to SARS-CoV-2 infection in lysosomal storage disorders 63
Predictors of Clinical Evolution in Prehypertrophic Fabry Disease 62
Totale 11.325
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.224
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.224
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202135 0 0 0 0 0 0 0 0 0 0 33 2
2021/2022500 11 22 4 32 47 13 8 97 22 44 101 99
2022/20231.445 160 152 119 203 66 167 95 138 144 112 67 22
2023/2024977 40 240 49 59 51 178 42 35 34 42 90 117
2024/20252.208 35 59 150 74 160 67 82 92 324 195 585 385
2025/20265.375 818 233 346 671 804 330 961 291 376 501 44 0
Totale 11.782